These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9504471)

  • 61. Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.
    Li BS; Regal J; Soher BJ; Mannon LJ; Grossman RI; Gonen O
    AJNR Am J Neuroradiol; 2003 Jan; 24(1):68-74. PubMed ID: 12533329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lesion load measurements in multiple sclerosis: the effect of incorporating magnetization transfer contrast in fast-FLAIR sequence.
    Filippi M; Rocca MA; Mastronardo G; Comi G
    Magn Reson Imaging; 1999 Apr; 17(3):459-61. PubMed ID: 10195590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification.
    Miki Y; Grossman RI; Udupa JK; Samarasekera S; van Buchem MA; Cooney BS; Pollack SN; Kolson DL; Constantinescu C; Polansky M; Mannon LJ
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):705-10. PubMed ID: 9127034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Implementation and evaluation of a new pulse sequence for rapid acquisition of double inversion recovery images for simultaneous suppression of white matter and CSF.
    Bedell BJ; Narayana PA
    J Magn Reson Imaging; 1998; 8(3):544-7. PubMed ID: 9626866
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Technical note: the comparison of hypointense lesions from 'pseudo-T1' and T1-weighted images in secondary progressive multiple sclerosis.
    Hickman SI; Barker GJ; Molyneux PD; Miller DH
    Mult Scler; 2002 Oct; 8(5):433-5. PubMed ID: 12356212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.
    Rovaris M; Comi G; Ladkani D; Wolinsky JS; Filippi M;
    AJNR Am J Neuroradiol; 2003 Jan; 24(1):75-81. PubMed ID: 12533330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diffusion tensor magnetic resonance imaging in multiple sclerosis.
    Filippi M; Cercignani M; Inglese M; Horsfield MA; Comi G
    Neurology; 2001 Feb; 56(3):304-11. PubMed ID: 11171893
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
    J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inversion-recovery echo-planar MR in adult brain neoplasia.
    Sheppard S; Davis PC; Kater G; Peterson JE
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):267-73. PubMed ID: 9504476
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis.
    Bonneville F; Moriarty DM; Li BS; Babb JS; Grossman RI; Gonen O
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):371-5. PubMed ID: 11901002
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study.
    Molyneux PD; Brex PA; Fogg C; Lewis S; Middleditch C; Barkhof F; Sormani MP; Filippi M; Miller DH
    Mult Scler; 2000 Aug; 6(4):237-40. PubMed ID: 10962544
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.
    Brex PA; Parker GJ; Leary SM; Molyneux PD; Barker GJ; Davie CA; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):627-32. PubMed ID: 10766895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.